TRUNATURE
Ginkgo Biloba With Vinpocetine
Avoid-flaggedObjective label signals
Flagged excipients
2
1 avoid · 1 caution
FDA recalls
0
no recall history
CAERS reports
8
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
2 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Ginkgo biloba extract Ginkgo | 120 mg | — |
| Vinpocetine UNII · 543512OBTC | 5 mg | — |
Flagged excipients
2 flagged · authority citations
- ● AVOIDTitanium Dioxide colorcolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
- ◐ CAUTIONGinkgo biloba extractother
IARC Group 2B (possibly carcinogenic to humans) based on NTP 2013 bioassay showing clear liver-tumor evidence in rodents. Also documented anticoagulant drug interactions.
FDA CAERS · adverse event context
8
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Soybean Oil · Gelatin · Glycerin · yellow Beeswax · Soy Lecithin · Vinpocetine · Carmel color